echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Beihai Kangcheng's new drug CAN108 for the treatment of Alagille syndrome has been officially accepted by the National Medical Products Administration (NMPA) and will be included in priority review

    Beihai Kangcheng's new drug CAN108 for the treatment of Alagille syndrome has been officially accepted by the National Medical Products Administration (NMPA) and will be included in priority review

    • Last Update: 2022-02-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com